Global Artificial Insemination Market to Reach US$ 4.2 Billion by 2032, Fueled by Expanding Fertility Sector

August 25, 2023 | Healthcare

According to the latest report by IMARC Group, titled “­­Artificial Insemination Market Report by Type (Intrauterine, Intracervical, Intravaginal, Intratubal), Source Type (AIH-Husband, AID-Donor), End Use (Hospitals and Clinics, Fertility Centers, and Others), and Region 2024-2032,” the global artificial insemination market size reached US$ 2.1 Billion in 2023. Artificial insemination refers to a medical technique utilized in human reproduction where sperm cells are deliberately introduced into the female reproductive system to facilitate fertilization. This method is employed when natural conception proves challenging or unfeasible due to various factors, such as fertility issues, sperm abnormalities, or unexplained infertility. The process involves collecting sperm from a male partner or a sperm donor, then preparing and concentrating the sperm sample to improve its viability. The concentrated sperm is then introduced into the woman's reproductive tract, usually through the cervix or directly into the uterus, bypassing potential barriers that could hinder natural conception. Artificial insemination is a less invasive and more affordable option compared to more advanced reproductive technologies and comes in different forms, including intrauterine insemination (IUI) and intracervical insemination (ICI), making it a popular choice for initial fertility treatments.


Global Artificial Insemination Market Trends:

The global artificial insemination market is mainly driven by the increasing prevalence of infertility among men and women caused by changing lifestyles, delayed pregnancies, and environmental factors. In line with this, the expanding awareness and acceptance of assisted reproductive techniques, combined with the rise in the number of individuals employing medical interventions to address infertility issues, is creating a positive outlook for market expansion. Moreover, significant advancements in reproductive technologies, the use of sophisticated laboratory techniques for processing and preparing sperm samples, and improved methods for selecting healthy and viable sperm have increased the success rates of artificial insemination, which, in turn, is aiding in market expansion. Concurrent with this, the development of advanced artificial insemination techniques, such as intracytoplasmic sperm injection (ICSI) and cryopreservation of sperm and embryos, has further improved patient outcomes, strengthening the market growth. Additionally, the evolving concept of family and changing social norms, with the increasing number of same-sex couples and single individuals exploring parenthood options, is contributing to the growth of the artificial insemination market. Furthermore, the emerging trends of medical tourism, as patients are increasingly willing to travel to different regions or countries to access high-quality fertility treatments, including artificial insemination, at competitive prices, are presenting remunerative growth opportunities for the market. Looking forward, the market value is projected to reach US$ 4.2 Billion by 2032, expanding at a CAGR of 7.5% during 2024-2032.


Market Summary:

  • Based on the type, the market is segregated into intrauterine, intracervical, intravaginal, and intratubal. Among these, the intrauterine segment dominates the market.
  • On the basis of the source type, the market has been bifurcated into AIH-husband and AID-donor.
  • Based on the end use, the market is categorized into hospitals and clinics, fertility centers, and others. Currently, fertility centers represent the largest market segment.
  • On a regional basis, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. Presently, North America enjoys the leading market position.
  • The competitive landscape of the market has also been examined, with some of the key players being Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women’s Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC and Vitrolife AB.


Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Source Type, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women’s Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC and Vitrolife AB
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Artificial Insemination Market to Reach US$ 4.2 Billion by 2032, Fueled by Expanding Fertility Sector
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More